Clinical significance of hepatitis C virus genotypes

Simmonds, 1995, Variability of hepatitis C virus, Hepatology, 21, 570, 10.1002/hep.1840210243 Okamoto, 1992, Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources, J Gen Virol, 73, 673, 10.1099/0022-1317-73-3-673 Ohno, 1997, New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a, J Clin Microbiol, 35, 201, 10.1128/JCM.35.1.201-207.1997 Stuyver, 1993, Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay, J Gen Virol, 74, 1093, 10.1099/0022-1317-74-6-1093 Davidson, 1995, Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region, J Gen Virol, 76, 1197, 10.1099/0022-1317-76-5-1197 Mondelli, 1994, Hepatitis C virus (HCV) core serotypes in chronic HCV infection, J Clin Microbiol, 32, 2523, 10.1128/JCM.32.10.2523-2527.1994 Machida, 1992, Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein, Hepatology, 16, 886, 10.1002/hep.1840160406 Bhattacherjee, 1995, Use of NS-4 peptides to identify type-specific antibody to genotypes 1, 2, 3, 4, 5 and 6, J Gen Virol, 76, 1737, 10.1099/0022-1317-76-7-1737 Lau, 1995, Applications of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States, J Infect Dis, 171, 281, 10.1093/infdis/171.2.281 Cerino, 1996, Comparative evaluation of two serologic typing methods of hepatitis C virus, J Clin Microbiol, 34, 714, 10.1128/JCM.34.3.714-716.1996 Pawlotski, 1997, Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay, J Clin Microbiol, 35, 1734, 10.1128/JCM.35.7.1734-1739.1997 McOmish, 1994, Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey, J Clin Microbiol., 32, 884, 10.1128/JCM.32.4.884-892.1994 Silini, 1995, Significance of hepatitis C virus genotypes, Viral Hepat Rev, 1, 111 Mahaney, 1994, Genotypic analysis of hepatitis C virus in American patients, Hepatology, 20, 1405, 10.1002/hep.1840200605 McOmish, 1993, Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities, Transfusion, 33, 7, 10.1046/j.1537-2995.1993.33193142314.x Nousbaum, 1995, Hepatitis C virus type 1b (II) infection in France and Italy, Ann Intern Med, 122, 161, 10.7326/0003-4819-122-3-199502010-00001 Viazov, 1997, Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan), J Med Virol, 53, 36, 10.1002/(SICI)1096-9071(199709)53:1<36::AID-JMV7>3.0.CO;2-R Puoti, 1997, Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels, Hepatology, 26, 1393, 10.1002/hep.510260603 Guadagnino, 1997, Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy, Hepatology, 26, 1006, 10.1002/hep.510260431 Osella, 1999, Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study, J Clin Microbiol, 37, 2371, 10.1128/JCM.37.7.2371-2372.1999 Silini, 1995, Molecular epidemiology of hepatitis C virus infection among intravenous drug users, J Hepatol, 22, 691, 10.1016/0168-8278(95)80225-8 Pol, 1995, The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients, Gastroenterology, 108, 581, 10.1016/0016-5085(95)90088-8 Pawlotsky, 1995, Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C, J Infect Dis, 171, 1607, 10.1093/infdis/171.6.1607 Bukh, 1993, At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide, Proc Natl Acad Sci USA, 90, 8234, 10.1073/pnas.90.17.8234 Simmonds, 1993, Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity, J Gen Virol, 74, 661, 10.1099/0022-1317-74-4-661 Zehender, 1995, HCV genotypes in bone marrow and peripheral blood mononuclear cells of patients with mixed cryoglobulinaemia, Clin Exp Rheumatol, 13, S87 Andreone, 1998, Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection, Ann Intern Med, 129, 294, 10.7326/0003-4819-129-4-199808150-00005 Frangeul, 1996, Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia, J Hepatol, 25, 427, 10.1016/S0168-8278(96)80200-5 Silvestri, 1996, Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders, Blood, 87, 4296, 10.1182/blood.V87.10.4296.bloodjournal87104296 Fattovich, 1997, Morbidity and mortality in compensated cirrhosis C: a retrospective study of 384 patients, Gastroenterology, 112, 462, 10.1053/gast.1997.v112.pm9024300 Pozzato, 1994, Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease, J Med Virol, 43, 291, 10.1002/jmv.1890430318 Mita, 1994, Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease, J Hepatol, 21, 468, 10.1016/S0168-8278(05)80330-7 Cathomas, 1996, Detection and typing of hepatitis C RNA in liver biopsies and its relation to histopathology, Virchows Arch, 429, 353, 10.1007/BF00198439 Zein, 1996, Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b, Am J Gastroenterol, 91, 2560 Zein, 1996, Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy, Ann Intern Med, 125, 634, 10.7326/0003-4819-125-8-199610150-00002 Booth, 1997, The relationship of histology to genotype in chronic HCV infection, Liver, 17, 144, 10.1111/j.1600-0676.1997.tb00797.x Naoumov, 1997, Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis, J Hepatol, 27, 331, 10.1016/S0168-8278(97)80179-1 Mangia, 1997, HCV genotypes in patients with liver disease of different stages and severity, J Hepatol, 26, 1173, 10.1016/S0168-8278(97)80449-7 Guido, 1996, Hepatitis C virus serotypes and liver pathology, Liver, 16, 353, 10.1111/j.1600-0676.1996.tb00761.x Ravaggi, 1996, Hepatitis C virus genotypes in northern Italy: clinical and virological features, J Clin Microbiol, 34, 2822, 10.1128/JCM.34.11.2822-2825.1996 Lee, 1996, Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea, J Med Virol, 49, 55, 10.1002/(SICI)1096-9071(199605)49:1<55::AID-JMV9>3.0.CO;2-J Silini, 1995, Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities, Hepatology, 21, 285 Yotsuyanagi, 1995, Hepatitis C virus genotypes and hepatocellular carcinoma, Cancer, 76, 1352, 10.1002/1097-0142(19951015)76:8<1352::AID-CNCR2820760809>3.0.CO;2-M Kleter, 1998, Hepatitis C virus genotypes: epidemiological and clinical associations, Liver, 18, 32, 10.1111/j.1600-0676.1998.tb00124.x Silini, 1995, Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities, Hepatology, 21, 285 Prati, 1996, Influence of different hepatitis C virus genotypes on the course of asymtomatic hepatitis C voris infection, Gastroenterology, 110, 178, 10.1053/gast.1996.v110.pm8536854 Rossini, 1997, Virological characterization and liver histology in HCV positive subjects with normal and elevated ALT, Liver, 17, 133, 10.1111/j.1600-0676.1997.tb00795.x Silini, 1996, Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study, Gastroenterology, 111, 199, 10.1053/gast.1996.v111.pm8698200 Hatzakis, 1996, Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study, Int J Cancer, 68, 51, 10.1002/(SICI)1097-0215(19960927)68:1<51::AID-IJC10>3.0.CO;2-9 Donato, 1997, Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma: a case-control study in Italy, Hepatology, 26, 579, 10.1002/hep.510260308 Kobayashi, 1996, The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses, Hepatology, 23, 695, 10.1002/hep.510230406 Bruno, 1997, Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study, Hepatology, 25, 754, 10.1002/hep.510250344 Takano, 1995, Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients, Hepatology, 21, 650, 10.1002/hep.1840210308 Benvegnù, 1997, Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis, Hepatology, 25, 211, 10.1002/hep.510250138 Serfaty, 1998, Determinants of outcome of compensated hepatitis C virus-related cirrhosis, Hepatology, 27, 1435, 10.1002/hep.510270535 Féray, 1995, Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation, Gastroenterology, 108, 1088, 10.1016/0016-5085(95)90207-4 Caccamo, 1996, Hepatitis C virus genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients, Transpl Int, 9, S204, 10.1111/j.1432-2277.1996.tb01610.x Belli, 1996, Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation, Liver Transpl Surg, 2, 200, 10.1002/lt.500020305 Gane, 1996, Long-term outcome of hepatitis C infection after liver transplantation, N Engl J Med, 34, 815, 10.1056/NEJM199603283341302 Gordon, 1997, Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation, Transplantation, 63, 1419, 10.1097/00007890-199705270-00009 Gayowski, 1997, Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome, Transplantation, 64, 422, 10.1097/00007890-199708150-00009 Zhou, 1996, Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia, Hepatology, 24, 1041, 10.1002/hep.510240510 Vargas, 1998, The influence of hepatitis C virus genotypes on the outcome of liver transplantation, Liver Transpl Surg, 4, 22, 10.1002/lt.500040103 Cacciola, 1999, Occult HBV infection in patients with chronic hepatitis C liver disease, N Engl J Med, 10.1056/NEJM199907013410104 Poynard, 1995, A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic Non-A, Non-B hepatitis, N Engl J Med, 332, 1457, 10.1056/NEJM199506013322201 Chemello, 1997, Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C, Gastroenterology, 113, 1654, 10.1053/gast.1997.v113.pm9352869 Bellobuono, 1997, Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis for factors predictive of sustained response to treatment, Eur J Gastroenterol Hepatol, 12, 1169 Farrell, 1998, Lymphoblastoid interferon alpha-n 1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alpha-2b: results of an international randomized controlled trial, Hepatology, 27, 1121, 10.1002/hep.510270429 Pawlotsky, 1998, Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations, J Virol, 72, 2795, 10.1128/JVI.72.4.2795-2805.1998 Brouwer, 1998, Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients, J Hepatol, 28, 951, 10.1016/S0168-8278(98)80342-5 Reichard, 1998, Randomised, double blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C, Lancet, 351, 83, 10.1016/S0140-6736(97)06088-1 Poynard, 1998, Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus, Lancet, 352, 1426, 10.1016/S0140-6736(98)07124-4 Yoshioka, 1992, Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus, Hepatology, 16, 293, 10.1002/hep.1840160203 Orito, 1994, Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy, J Hepatol, 21, 130, 10.1016/S0168-8278(94)80149-5 Mita, 1994, Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer, Dig Dis Sci, 39, 977, 10.1007/BF02087547 Matsumoto, 1994, Viral and host factors that contribute to the efficacy on interferonalpha 2a therapy in patients with chronic hepatitis C, Dig Dis Sci, 39, 1273, 10.1007/BF02093793 Tsubota, 1994, Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection, Hepatology, 19, 1088, 10.1002/hep.1840190505 Martinot-Peignoux, 1995, Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alpha therapy in chronic hepatitis C, Hepatology, 22, 1050, 10.1002/hep.1840220406 Yuki, 1995, Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes, J Med Virol, 45, 162, 10.1002/jmv.1890450209 Chemello, 1995, Randomized trial comparing three different regimens of alpha 2a-interferon in chronic hepatitis C, Hepatolology, 22, 700 Lindsay, 1996, Response to higher doses of interferon alpha-2b in patients with chronic hepatitis C: a randomized multicenter trial, Hepatology, 24, 1034 Mizokami, 1996, Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C, Liver, 16, 23, 10.1111/j.1600-0676.1996.tb00699.x Hopf, 1996, Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes, J Hepatol, 24, 67 McHutchison, 1998, Interferon Alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C, N Engl J Med, 339, 1485, 10.1056/NEJM199811193392101 Davis, 1998, Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C, N Engl J Med, 339, 1493, 10.1056/NEJM199811193392102 Liang, 1998, Combination therapy for hepatitis C infection, N Engl J Med, 339, 1549, 10.1056/NEJM199811193392112